Studies on rapid weight loss show that patients consistently report cold intolerance during the first few months
LID mice showed relatively normal development despite the reduction in serum IGF-I levels by 75%
However, the most important clinical signal is not the dose number itself, but rather, it is whether your body is responding, tolerating the medication, and continuing to progress
Baseline meal-stimulated GLP-1 responses were not associated with treatment-related weight loss, the authors said
To date, there is only one published human study of BPC-157: a retrospective survey of sixteen people who had it injected into a painful knee, with no control group and no placebo, asked months later whether they felt better [14]
Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C